SEARCH:   Advanced

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hartman, M.-L. Articles by Levi-Schaffer, F. Search for Related Content PubMed PubMed Citation Articles by Hartman, M.-L. Articles by Levi-Schaffer, F. Related Collections Hematopoiesis and Stem Cells Phagocytes Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 February 2001, Vol. 97, No. 4, pp. 1086-1091 PHAGOCYTES Human peripheral blood eosinophils express stem cell factor Mor-Li Hartman, Adrian M. Piliponsky, Vladislav Temkin, and Francesca Levi-Schaffer From the Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. Stem cell factor (SCF) or c-Kit ligand is a cytokine associated with the differentiation, survival, and activation of mast cells. Eosinophils have pleiotropic functions in several diseases and, together with mast cells, are key cells in allergy. Mast cell-eosinophil interactions can take place during the late and chronic phases of allergy. It was, therefore, investigated whether eosinophils can produce SCF and consequently influence mast cells. Human peripheral blood eosinophils variably expressed mRNA for the soluble and uncleaved forms of SCF (reverse transcription-polymerase chain reaction) and produced the 18.5-kd protein backbone of SCF (Western blot analysis). After overnight incubation in medium, eosinophils also produced SCF of higher molecular weight (42-45 kd) that might represent its glycosylated forms. Eosinophils expressed cytoplasmic SCF that colocalized with major basic protein (confocal laser microscopy). Freshly isolated eosinophils contained 8.9 ± 1.7 pg SCF/106 (mean ± SEM; enzyme-linked immunosorbent assay). Although overnight incubation of the eosinophils in either culture medium or in phorbol 12-myristate 13-acetate-calcium ionophore did not cause the secretion of SCF, the addition of chymase induced SCF release. In summary, it was demonstrated that human peripheral blood eosinophils are a source of SCF. These results may contribute to a better understanding of the interactions between eosinophils and mast cells in allergic inflammation. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: R. C. N. Melo, L. A. Spencer, A. M. Dvorak, and P. F. Weller Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins J. Leukoc. Biol., February 1, 2008; 83(2): 229 - 236. [Abstract] [Full Text] [PDF] I. Bachelet, A. Munitz, D. Mankutad, and F. Levi-Schaffer Mast Cell Costimulation by CD226/CD112 (DNAM-1/Nectin-2): A NOVEL INTERFACE IN THE ALLERGIC PROCESS J. Biol. Chem., September 15, 2006; 281(37): 27190 - 27196. [Abstract] [Full Text] [PDF] H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF] A. Munitz, I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H.-U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer 2B4 (CD244) Is Expressed and Functional on Human Eosinophils J. Immunol., January 1, 2005; 174(1): 110 - 118. [Abstract] [Full Text] [PDF] J. Cortes, P. Ault, C. Koller, D. Thomas, A. Ferrajoli, W. Wierda, M. B. Rios, L. Letvak, E. S. Kaled, and H. Kantarjian Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome Blood, June 15, 2003; 101(12): 4714 - 4716. [Abstract] [Full Text] [PDF] A. Pardanani, T. Reeder, L. F. Porrata, C.-Y. Li, H. D. Tazelaar, E. J. Baxter, T. E. Witzig, N. C. P. Cross, and A. Tefferi Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders Blood, May 1, 2003; 101(9): 3391 - 3397. [Abstract] [Full Text] [PDF] A. M. Piliponsky, G. J. Gleich, A. Nagler, I. Bar, and F. Levi-Schaffer Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor Blood, March 1, 2003; 101(5): 1898 - 1904. [Abstract] [Full Text] [PDF] G. Woerly, P. Lacy, A. B. Younes, N. Roger, S. Loiseau, R. Moqbel, and M. Capron Human eosinophils express and release IL-13 following CD28-dependent activation J. Leukoc. Biol., October 1, 2002; 72(4): 769 - 779. [Abstract] [Full Text] [PDF] V. Temkin, B. Kantor, V. Weg, M.-L. Hartman, and F. Levi-Schaffer Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release J. Immunol., September 1, 2002; 169(5): 2662 - 2669. [Abstract] [Full Text] [PDF] E. Zamir, H. Mechoulam, A. Micera, F. Levi-Schaffer, and J. Pe'er Inflamed juvenile conjunctival naevus: clinicopathological characterisation Br. J. Ophthalmol., January 1, 2002; 86(1): 28 - 30. [Abstract] [Full Text] [PDF]

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020